From Nasdaq: 2024-11-11 16:00:01

Astrazeneca PLC (AZN) is expected to report earnings of $1.01 per share for the quarter ending September 30, 2024, representing a 16.09% increase from the same quarter a year ago. Roivant Sciences Ltd. (ROIV) is expected to report earnings of $-0.27 per share, a decrease of -18.18%. Repligen Corporation (RGEN) is expected to report earnings of $0.34 per share, a 47.83% increase from last year.

Legend Biotech Corporation (LEGN) is expected to report earnings of $-0.56 per share, a significant increase of 229.41% from the same quarter a year ago. Axsome Therapeutics, Inc. (AXSM) is expected to report earnings of $-1.38 per share, a 4.55% increase. Surgery Partners, Inc. (SGRY) is expected to report earnings of $0.21 per share, a 40.00% increase from last year.

Camtek Ltd. (CAMT) is expected to report earnings of $0.64 per share, a 39.13% increase from the same quarter a year ago. EchoStar Corporation (SATS) is expected to report earnings of $-0.28 per share, a significant decrease of -286.67%. Zai Lab Limited (ZLAB) is expected to report earnings of $-0.75 per share, a 5.63% increase.

First Advantage Corporation (FA) is expected to report earnings of $0.23 per share, an 8.00% decrease from last year. SpringWorks Therapeutics, Inc. (SWTX) is expected to report earnings of $-0.76 per share, a decrease of -40.16%. Neumora Therapeutics, Inc. (NMRA) is expected to report earnings of $-0.38 per share, a decrease of -66.67%.



Read more at Nasdaq:: Pre-Market Earnings Report for November 12, 2024 : AZN, ROIV, RGEN, LEGN, AXSM, SGRY, CAMT, SATS, ZLAB, FA, SWTX, NMRA